GENOME ANNOUNCEMENT
===================

*Klbesiella pneumoniae* is a Gram-negative rod-shaped bacteria belonging to the *Enterobacteriaceae* family ([@B1]). It is considered one of the most important human pathogens and frequently causes many diseases, including pneumonia, urinary tract infection, and septicemia ([@B2], [@B3]). The rise of multidrug-resistance in *K. pneumoniae* has raised serious therapeutic challenges ([@B4]) because patients infected by carbapenem-resistant KPC-producing *K. pneumoniae* have shown high rates of mortality ([@B5]). *K. pneumoniae* acquired multidrug resistance through horizontal gene transfer via mobile genetic elements, including carbapenemases ([@B6]). That might explain why it spreads quickly in the hospital environment.

XH209 is a multidrug-resistant *K. pneumoniae* strain isolated from the blood of a patient in Hangzhou, Zhejiang, China, during tigecycline treatment. It could be a reference genome for further comparative analysis of tigecycline resistance in *K. pneumoniae*. The strain belongs to sequence type (ST) 17. The strain demonstrated multiple resistances to clinically used antibiotics, including all β-lactams, sulfonamides, and tetracycline, but it was susceptible to tigecycline and colistin.

A single colony of *K. pneumoniae* XH209 was grown in 2 mL of Müller-Hinton broth overnight at 37°C. The genomic DNA of *K. pneumoniae* was extracted using the QIAamp DNA minikit (Qiagen, Valencia, CA, USA) following the manufacturer's protocol ([@B7]). The quality and quantity of extracted genomic DNA were determined by agarose gel and NanoDrop spectrophotometer. Five µg of genomic DNA was used to construct a 300-bp library for Illumina paired-end sequencing. Furthermore, to finish the complete genome of XH209, an 8-kb mate-pair library was also prepared for XH209. The raw Illumina sequencing data was *de novo* assembled via IDBA-Hybrid ([@B8]). Then, SSPACE was used to scaffold the preassembled contigs ([@B9]), and GapFiller was used to close the gaps within the scaffolds ([@B10]). The rest of the gaps were filled by PCR and Sanger sequencing.

The complete genome of *K. pneumoniae* strain XH209 comprised 5,118,878 bp with a GC content of 57.63%. Automatic genome annotation was performed using the NCBI Prokaryotic Genome Annotation Pipeline (<http://www.ncbi.nlm.nih.gov/genome/annotation_prok>), which predicted a total of 5,023 genes, 4,881 coding sequences, 28 pseudogenes, 25 rRNAs (5S, 16S, 23S), 85 tRNAs, 4 noncoding RNAs, and 20 frameshifted genes.

As mentioned previously, *K. pneumoniae* XH209 was isolated during tigecycline treatment. Furthermore, six independent laboratory evolution mutants were obtained after treating strain XH209 with an increased concentration of tigecycline. Whole-genome sequencing and transcriptome experiment were performed to investigate the tigecycline-resistance mechanism in *K. pneumoniae* and will be reported in a future publication*.*

Nucleotide sequence accession number. {#h1}
-------------------------------------

This complete genome sequence of *K. pneumoniae* XH209 has been deposited at DDBJ/EMBL/GenBank under the accession number [CP009461](CP009461).
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